From: Synthesis and biological activity of myricetin derivatives containing 1,3,4-thiadiazole scaffold
Compd. | Curative activity (%) | Protection activity (%) | Compd. | Curative activity (%) | Protection activity (%) |
---|---|---|---|---|---|
2 | 18.2 ± 7.3 | 21.5 ± 9.1 | 3j | 28.7 ± 3.8 | 39.4 ± 3.1 |
3a | 46.7 ± 5.2 | 50.3 ± 9.3 | 3k | 28.0 ± 8.6 | 33.0 ± 7.5 |
3b | 53.8 ± 9.0 | 54.1 ± 9.4 | 3l | 33.9 ± 9.4 | 34.2 ± 5.4 |
3c | 37.0 ± 9.1 | 58.4 ± 1.0 | 3m | 57.1 ± 9.6 | 56.7 ± 8.2 |
3d | 59.8 ± 9.2 | 54.3 ± 9.0 | 3n | 48.4 ± 5.9 | 42.1 ± 7.1 |
3e | 28.7 ± 8.3 | 35.4 ± 5.1 | 3o | 50.8 ± 3.6 | 47.3 ± 2.9 |
3f | 68.4 ± 7.4 | 54.4 ± 7.7 | 3p | 34.6 ± 5.4 | 36.5 ± 1.6 |
3g | 36.4 ± 3.8 | 38.6 ± 7.7 | Myricetin a | 28.8 ± 6.7 | 34.4 ± 7.2 |
3 h | 44.8 ± 9.4 | 45.2 ± 1.5 | Ningnanmycin a | 51.8 ± 4.3 | 58.3 ± 2.9 |
3i | 66.8 ± 9.8 | 60.8 ± 8.3 |